Study of different formulations of an intramuscular A/H5N1 inactivated, split virion influenza adjuvanted vaccine [influenza A virus vaccine-H5N1]
Phase of Trial: Phase I
Latest Information Update: 15 Apr 2011
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions
- 15 Apr 2011 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 12 Feb 2010 Planned end date changed from 1 Jun 2009 to 1 May 2010 as reported by ClinicalTrials.gov.
- 14 May 2008 New trial record.